Relapse of Kaposi's sarcoma in HIV-infected patients switching from a protease inhibitor to a non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy regimen

被引：20

作者：

Bani-Sadr, F ^{[1
]}

Fournier, S ^{[1
]}

Molina, LM ^{[1
]}

机构：

[1] Hop St Louis, Serv Maladies Infect & Trop, Paris, France

来源：

AIDS | 2003年 / 17卷 / 10期

关键词：

D O I：

10.1097/00002030-200307040-00028

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1580 / 1581

页数：2

共 5 条

[1] Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients [J].

Dupont, C ;

Vasseur, E ;

Beauchet, A ;

Aegerter, P ;

Berthé, H ;

de Truchis, P ;

Zucman, D ;

Rouveix, E ;

Saiag, P .

AIDS, 2000, 14 (08) :987-993

[2] Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination antiretroviral therapy [J].

Grulich, AE ;

Li, YM ;

McDonald, AM ;

Correll, PK ;

Law, MG ;

Kaldor, JM .

AIDS, 2001, 15 (05) :629-633

[3] Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma [J].

Lebbé, C ;

Blum, L ;

Pellet, C ;

Blanchard, G ;

Vérola, O ;

Morel, P ;

Danne, O ;

Calvo, F .

AIDS, 1998, 12 (07) :F45-F49

[4] Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma [J].

Pati, S ;

Pelser, CB ;

Dufraine, J ;

Bryant, JL ;

Reitz, MS ;

Weichold, FF .

BLOOD, 2002, 99 (10) :3771-3779

[5] HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma [J].

Sgadari, C ;

Barillari, G ;

Toschi, E ;

Carlei, D ;

Bacigalupo, I ;

Baccarini, S ;

Palladino, C ;

Leone, P ;

Bugarini, R ;

Malavasi, L ;

Cafaro, A ;

Falchi, M ;

Valdembri, D ;

Rezza, G ;

Bussolino, F ;

Monini, P ;

Ensoli, B .

NATURE MEDICINE, 2002, 8 (03) :225-232

← 1 →